Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
Recruiting
Early Phase 1
Interventional Study
Radiotracer
Hypertension
Cholesterol
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 24 (estimated)
- Sponsor
- Benjamin Viglianti · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate the feasibility of using a sub-therapeutic dose of a fluorine-18 analogue of NP-59 (\[18F\]FNP-59) to image the adrenal gland. Some participants are healthy normal subjects but have undergone interventions to manipulate hormones while other participants have known adrenal pathology.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (Groups 2 \& 3):
* Participants without any known adrenal pathology as normal controls for undergoing endocrine manipulation
Exclusion Criteria (Groups 2 \& 3):
* Pregnancy
* Unable to do imaging
* Body weight greater than 400 lbs (181 Kg)
* Prisoners are not eligible
* Subject…
Contacts